Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.
Previous studies established that vaccinia virus could enter cells by fusion with the plasma membrane at neutral pH. However, low pH triggers fusion of vaccinia virus-infected cells, a hallmark of viruses that enter by the endosomal route. Here, we demonstrate that entry of mature vaccinia virions is accelerated by brief low-pH treatment and severely reduced by inhibitors of endosomal acidification, providing evidence for a predominant low-pH-dependent endosomal pathway. Entry of vaccinia virus cores into the cytoplasm, measured by expression of firefly luciferase, was increased more than 10-fold by exposure to a pH of 4.0 to 5.5. Furthermore, the inhibitors of endosomal acidification bafilomycin A1, concanamycin A, and monensin each lowered virus entry by more than 70%. This reduction was largely overcome by low-pH-induced entry through the plasma membrane, confirming the specificities of the drugs. Entry of vaccinia virus cores with or without brief low-pH treatment was visualized by electron microscopy of thin sections of immunogold-stained cells. Although some virus particles fused with the plasma membrane at neutral pH, 30 times more fusions and a greater number of cytoplasmic cores were seen within minutes after low-pH treatment. Without low-pH exposure, the number of released cores lagged behind the number of virions in vesicles until 30 min posttreatment, when they became approximately equal, perhaps reflecting the time of endosome acidification and virus fusion. The choice of two distinct pathways may contribute to the ability of vaccinia virus to enter a wide range of cells.
Townsley
Alan C
AC
Laboratory of Viral Diseases, National Institutes of Health, 4 Center Drive, MSC 0445, Bethesda, MD 20892-0445, USA.
Weisberg
Andrea S
AS
Wagenaar
Timothy R
TR
Moss
Bernard
B
D002460:Cell Line; D002462:Cell Membrane / Q000648:ultrastructure / Q000821:virology; D003593:Cytoplasm / Q000378:metabolism; D011992:Endosomes / Q000378:metabolism / Q000648:ultrastructure / Q000821:virology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007476:Ionophores / Q000494:pharmacology; D018942:Macrolides / Q000494:pharmacology; D018613:Microscopy, Confocal; D008985:Monensin / Q000494:pharmacology; D013997:Time Factors; D014616:Vaccinia virus / Q000378:metabolism*
D004791:Enzyme Inhibitors; D007476:Ionophores; D018942:Macrolides; C036978:concanamycin A; C040929:bafilomycin A1; D008985:Monensin